CJC-1295 (No DAC) + Ipamorelin 10mg Blend Peptide Australia

CJC-1295 (No DAC) + Ipamorelin 10mg Blend is a dual-compound research peptide formulation designed for laboratory studies focused on growth hormone signalling, endocrine response patterns, and metabolic pathway analysis. This combination pairs a GHRH analogue (CJC-1295 No DAC) with a growth hormone secretagogue (Ipamorelin), creating a model for investigating coordinated hormonal pathway activation.

For researchers looking to buy peptides online in Australia, this blend is widely used in experimental settings examining the growth hormone (GH) and insulin-like growth factor-1 (IGF-1) axis, which plays a central role in cellular signalling, energy regulation, and physiological balance. The short-acting nature of CJC-1295 (No DAC) allows for controlled, pulsatile signalling, while Ipamorelin is studied for its selective interaction with ghrelin receptor pathways.

In controlled laboratory environments, this combination is frequently utilised to explore hormonal release dynamics, receptor interaction timing, and endocrine signalling efficiency. Its dual-action profile makes it particularly relevant for research investigating synergistic peptide interactions and coordinated GH pathway activation.

This blend is also referenced in broader discussions around peptide stacks for sale and longevity peptides protocols, where multi-compound strategies are used to analyse hormonal signalling optimisation and metabolic response models. Researchers value this combination for its ability to provide insight into short-duration signalling cycles and integrated endocrine responses.

Our CJC-1295 (No DAC) + Ipamorelin 10mg Blend is manufactured under strict quality-controlled conditions and undergoes peptide purity verification with ≥99% HPLC-tested standards. Supplied as a stable white lyophilized powder, it ensures precision, consistency, and reliability in laboratory research applications. PrimePeptix is committed to being a most trusted peptide source in Australia (2026).